Gilead Sciences Inc
MIL:1GILD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gilead Sciences Inc
MIL:1GILD
|
US |
|
K
|
Kroger Co
F:KOG
|
US |
|
U
|
UPM-Kymmene Oyj
XMUN:RPL
|
FI |
|
D
|
Digital China Holdings Ltd
XBER:DIN
|
HK |
|
A
|
Arcosa Inc
F:EOB
|
US |
|
N
|
Nippon Yusen KK
OTC:NYUKF
|
JP |
|
JFE Holdings Inc
F:JFR
|
JP |
|
Interroll Holding AG
F:I3H
|
CH |
|
D
|
Domain Holdings Australia Ltd
OTC:DHGAF
|
AU |
|
O
|
Obsidian Energy Ltd
F:P13A
|
CA |
|
C
|
Construcciones Y Auxiliar De Ferrocarriles SA
MAD:CAF
|
ES |
|
Elbit Systems Ltd
NASDAQ:ESLT
|
IL |
|
N
|
Natural Gas Services Group Inc
XBER:NGS
|
US |
|
COSCO Shipping Energy Transportation Co Ltd
F:HIFH
|
CN |
|
B
|
Baidu Inc
DUS:B1CB
|
CN |
|
A
|
Alps Alpine Co Ltd
SWB:ALE
|
JP |
|
M
|
MC Mining Ltd
JSE:MCZ
|
AU |
|
C
|
Corpfin Capital Prime Retail II Socimi SA
F:F95
|
ES |
|
M
|
MGM Resorts International
DUS:MGG
|
US |
|
M
|
Mitsubishi Heavy Industries Ltd
F:MIH
|
JP |
|
O
|
Oracle Corp
XHAM:ORC
|
US |
Bankruptcy Probability
Gilead Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gilead Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
293.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
91B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
28.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gilead Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gilead Sciences Inc has total debt of 20.9B USD. This includes both short-term (0 USD) and long-term (20.9B USD) debt.
You can find a full breakdown on its Balance Sheet.
